No Data
No Data
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/16)
[Good Material] ――――――――――■Mitsui Matsushima Holdings [Tokyo Stock Exchange P] City Index Eleven submitted a change report on the 16th. The shareholding ratio of Mitsui Matsushima HD, a co-owner of City Index Eleven, increased from 11.22% to 14.56%. ■Dawn [Tokyo Stock Exchange S] The Fukuoka City Waterworks Bureau conducted a demonstration test of “remote work support for maintenance and management of equipment using smart glasses, etc.,” video call system
The Tokyo Stock Exchange Growth Index continued to decline drastically, and the main stocks continued to weaken and hit year-to-date lows
TSE Growth Market Index 812.88 -11.82 /volume 115.04 million shares/trading price 126.7 billion yen TSE growth market 250 index 635.09 -8.43/turnover 91.19 million shares/trading price 112.2 billion yen Today's growth market continues to decline drastically in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks is 182, the number of falling stocks is 369, and 25 unchanged. The US stock market continued to rise on the 15th. The Dow Jones Industrial Average rose by $349.89 (+
High stop/low stop-down stocks backstage
■Stop Taka<1514>Sumiseki Holdings<1730>Aso Fromcleat <2813>Kazuhiro Foods<3393>Startia Holdings<6085>Architects Studio Japan <6533>Orchestra Holdings<7042>Access Group Holdings <7886>Yamato Industries■Stop An 270<8>Kuze <2928>Rizap Group<4492> Genetec <4598>
Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/15)
[Good news] ---- ---- ■ITbook Holdings [Tokyo Stock Exchange G] Current financial results increased 26% to the highest profit for 4 consecutive terms, to 6 yen this fiscal year. ■GNI Group [TSE G] landed in surplus at the end of the January-March period (1Q). Also, we will proceed with preparations for applying for a market classification change to the Tokyo Stock Exchange Prime Market. In addition, a joint venture for drug discovery and investment businesses utilizing AI technology will be established with Oltz and Governance Partners. ■Huh
INBOUND PLATFORM: Confirmation Letter
INBOUND PLATFORM: Quarterly Report - 9th Quarter (2024/01/01 - 2024/03/31)
No Data